Cargando…
High endothelial venules predict response to PD-1 inhibitors combined with anti-angiogenesis therapy in NSCLC
Tumor-associated high endothelial venules (TA-HEVs) mediate lymphocyte entry into tumors. Therefore, combined anti-angiogenesis therapy and programmed death-1 (PD-1) inhibitors might stimulate tumor immunity. This study will explore the TA-HEVs and real-world data of the combination therapy in non-s...
Autores principales: | Ye, Dafu, Jin, Yao, Weng, Yiming, Cui, Xue, Wang, Jinsong, Peng, Min, Song, Qibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543372/ https://www.ncbi.nlm.nih.gov/pubmed/37777573 http://dx.doi.org/10.1038/s41598-023-43122-w |
Ejemplares similares
-
High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration
por: Chen, Huiyuan, et al.
Publicado: (2022) -
Angiogenesis Inhibitors in NSCLC
por: Manzo, Anna, et al.
Publicado: (2017) -
Understanding high endothelial venules: Lessons for cancer immunology
por: Ager, Ann, et al.
Publicado: (2015) -
High endothelial venules (HEVs) in immunity, inflammation and cancer
por: Blanchard, Lucas, et al.
Publicado: (2021) -
High endothelial venules: Help or hindrance in the quest for antitumor immunity?
por: Gallimore, Awen, et al.
Publicado: (2013)